日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors

免疫检查点抑制剂和致癌病毒在实体瘤中的疗效

Mechahougui, Hiba; Royston, Léna; Vieira Gomes, Catia; Kaiser, Laurent; Koessler, Thibaud; Olivier, Timothée; Mach, Nicolas; Labidi-Galy, S Intidhar; Parikh, Kaushal; Addeo, Alfredo

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy

新辅助化疗免疫疗法治疗IIIA期非小细胞肺癌患者的肿瘤免疫动力学和长期临床结果

Schmid, Dominic; Sobottka, Bettina; Manzo, Massimiliano; Trüb, Marta; Leonards, Katharina; Herzig, Petra; Oyewole, Oluwaseun Rume-Abiola; Jermann, Philip; Hayoz, Stefanie; Savic Prince, Spasenija; Tochtermann, Giulia; Natoli, Marina; Pless, Miklos; Bettini, Adrienne; Früh, Martin; Mauti, Laetitia A; Britschgi, Christian; Peters, Solange; Mark, Michael; Ochsenbein, Adrian F; Janthur, Wolf-Dieter; Waibel, Christine; Mach, Nicolas; Froesch, Patrizia; Buess, Martin; Bohanes, Pierre; Gonzalez, Michel; Alborelli, Ilaria; Rothschild, Sacha I; Koelzer, Viktor Hendrik; Zippelius, Alfred

Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy: results of SAKK 11/16, a phase IIa trial.

接受至少 1 线系统治疗后进展的复发/转移性头颈部鳞状细胞癌患者的总体生存率,采用新型的、首创的基于细胞封装的免疫疗法 MVX-ONCO-1 进行治疗:SAKK 11/16 IIa 期试验的结果

Fernandez Eugenio, Vernet Rémi, Urwyler Muriel, Von Rohr Olivier, Charrier Emily, Belkouch Marie-Claude, Saingier Valentin, Courtout Fabien, DeVito Claudio, Ancrenaz Virginie, Dulguerov Nicolas, Karenovics Wolfram, Grogg Julien, Renaux Jessica, Gobat Katrin, Müller Gisela, Brezina Tomas, Rordorf Tamara, Joerger Markus, Michielin Olivier, Villard Jean, Mach Nicolas

Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre study

Sabatolimab联合spartalizumab治疗既往接受过抗PD-1/PD-L1治疗的非小细胞肺癌或黑色素瘤患者:一项II期多中心研究

Lin, Chia-Chi; Curigliano, Giuseppe; Santoro, Armando; Kim, Dong-Wan; Tai, David; Hodi, F Stephen; Wilgenhof, Sofie; Doi, Toshihiko; Sabatos-Peyton, Catherine; Szpakowski, Sebastian; Chitnis, Shripad; Xyrafas, Alexandros; Gutzwiller, Sabine; Pastore, Alessandro; Mach, Nicolas

Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma: Insights from real-life clinical practice

分次注射利妥昔单抗预防侵袭性B细胞淋巴瘤肿瘤溶解综合征的有效性:来自真实临床实践的启示

Mohamad, Jasmine; Bouroumeau, Antonin; McKee, Thomas A; Mach, Nicolas; Samii, Kaveh; Chamuleau, Martine; Stenner, Frank; Tamburini, Jerome; Lang, Noémie

Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)

伊布替尼和硼替佐米联合治疗后进行伊布替尼维持治疗,用于治疗复发或难治性套细胞淋巴瘤和高危特征:欧洲 MCL 网络的 1/2 期试验 (SAKK 36/13)

Novak, Urban; Fehr, Martin; Schär, Sämi; Dreyling, Martin; Schmidt, Christian; Derenzini, Enrico; Zander, Thilo; Hess, Georg; Mey, Ulrich; Ferrero, Simone; Mach, Nicolas; Boccomini, Carola; Böttcher, Sebastian; Voegeli, Michèle; Cairoli, Anne; Ivanova, Vanesa-Sindi; Menter, Thomas; Dirnhofer, Stefan; Scheibe, Bernhard; Gadient, Sandra; Eckhardt, Katrin; Zucca, Emanuele; Driessen, Christoph; Renner, Christoph

Erratum: Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology

勘误:利用细胞封装技术递送治疗性蛋白的永生化人类成肌细胞系

Lathuiliere, Aurelien; Vernet, Remi; Charrier, Emily; Urwyler, Muriel; Von Rohr, Olivier; Belkouch, Marie-Claude; Saingier, Valentin; Bouvarel, Thomas; Guillarme, Davy; Engel, Adrien; Salmon, Patrick; Laumonier, Thomas; Grogg, Julien; Mach, Nicolas

SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients

SARS-CoV-2 mRNA疫苗在免疫功能低下患者中的反应:一项单中心研究比较了癌症患者、艾滋病毒感染者、造血干细胞移植患者和肺移植受者

Bordry, Natacha; Mamez, Anne-Claire; Fedeli, Chiara; Cantero, Chloé; Jaksic, Cyril; Alonso, Pilar Ustero; Rayroux, Caroline; Berra, Gregory; Portillo, Vera; Puntel, Maeva; Yerly, Sabine; Bugeia, Sébastien; Gutknecht, Garance; Di Marco, Mariagrazia; Mach, Nicolas; Soccal, Paola Marina; Chalandon, Yves; Calmy, Alexandra; Addeo, Alfredo

Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity

Nab-PIPAC:一项 IB 期研究方案,旨在评估通过加压腹腔内气溶胶化疗 (PIPAC) 给药,腹腔内注射顺铂和白蛋白结合型紫杉醇治疗局限于腹膜腔的晚期恶性肿瘤的疗效。

Lang, Noemie; Diciola, Antonella; Labidi-Galy, Intidhar; Ris, Frédéric; Di Marco, Mariagrazia; Mach, Nicolas; Petignat, Patrick; Toso, Christian; Undurraga, Manuela; Hubner, Martin

SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

SAKK 35/15:一项评估奥妥珠单抗联合维奈托克治疗既往未接受治疗的滤泡性淋巴瘤患者的 I 期临床试验

Stathis, Anastasios; Mey, Ulrich; Schär, Sämi; Hitz, Felicitas; Pott, Christiane; Mach, Nicolas; Krasniqi, Fatime; Novak, Urban; Schmidt, Christian; Hohloch, Karin; Kienle, Dirk Lars; Hess, Dagmar; Moccia, Alden A; Unterhalt, Michael; Eckhardt, Katrin; Hayoz, Stefanie; Forestieri, Gabriela; Rossi, Davide; Dirnhofer, Stefan; Ceriani, Luca; Sartori, Giulio; Bertoni, Francesco; Buske, Christian; Zucca, Emanuele; Hiddemann, Wolfgang